Nalaganje...
Benralizumab: a unique IL-5 inhibitor for severe asthma
The presence of eosinophilic inflammation is a characteristic feature of chronic and acute inflammation in asthma. An estimated 5%–10% of the 300 million people worldwide who suffer from asthma have a severe form. Patients with eosinophilic airway inflammation represent approximately 40%–60% of this...
Shranjeno v:
| izdano v: | J Asthma Allergy |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Dove Medical Press
2016
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4831605/ https://ncbi.nlm.nih.gov/pubmed/27110133 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/JAA.S78049 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|